创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Core Advantages of the ELISA Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-15 14:00
  • Views:

(Summary description)In the field of biomedical research, accurate and efficient assays are the key to advancing scientific research. With its leading ELISA platform, InnoModels Biotechnology provides researchers with a powerful and reliable experimental tool to help them make breakthroughs in the field of life sciences

InnoModels Biotechnology: Core Advantages of the ELISA Platform

(Summary description)In the field of biomedical research, accurate and efficient assays are the key to advancing scientific research. With its leading ELISA platform, InnoModels Biotechnology provides researchers with a powerful and reliable experimental tool to help them make breakthroughs in the field of life sciences

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-15 14:00
  • Views:
Information

In the field of biomedical research, accurate and efficient assays are the key to advancing scientific research. With its leading ELISA platform, InnoModels Biotechnology provides researchers with a powerful and reliable experimental tool to help them make breakthroughs in the field of life sciences.
High sensitivity and specificity
InnoModels' ELISA platform is known for its outstanding sensitivity and specificity. Through precise antigen-antibody reactions, the platform is able to accurately detect very low concentrations of target molecules while avoiding interference from non-specific signals. This high degree of accuracy and reliability makes the results more convincing and provides strong data support for researchers.
Wide range of applications
InnoModels' ELISA platform has a wide range of applications and can be used for the detection of a wide variety of biological samples, including serum, plasma, tissue homogenates, and so on. In addition, the platform can be used to detect a wide range of biomolecules, such as proteins, hormones, antibodies, etc., to meet the needs of different research projects.
Flexibility and customizability

 


Focusing on customer needs, InnoModels Biotechnology provides highly flexible and customizable ELISA services. Customers can choose different reagents, antibodies and experimental procedures according to their experimental needs in order to obtain the best experimental results. In addition, InnoModels Biotechnology also provides personalized technical support and solutions to help customers solve problems encountered in their experiments.
High-throughput processing capability
As scientific research continues to deepen, the demand for experimental throughput is also increasing. InnoModels Bio's ELISA platform is equipped with highly efficient processing capability, which can process multiple samples at the same time, greatly improving the efficiency of experiments. This high throughput capability enables researchers to obtain a large amount of data in a short period of time, accelerating the research process.
Strict Quality Control
InnoModels Biotechnology has implemented strict quality control measures during the development and production of its ELISA platform. From the screening of reagents, preparation of antibodies to the optimization of the experimental process, each step is carefully designed and rigorously verified to ensure the accuracy and reliability of the experimental results. This persistent pursuit of quality has made Thermo Scientific's ELISA platform earn a good reputation in the scientific research field.
In conclusion, with its high sensitivity, wide range of applications, flexibility and customizability, high-throughput processing capability, and strict quality control, InnoModels' ELISA platform provides a powerful and reliable experimental tool for researchers. In the future, InnoModels Biotechnology will continue to optimize and improve the ELISA platform to contribute more to the development of life science field. We are looking forward to working with more researchers to promote the progress of scientific research.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司